Biocryst Pharmaceuticals buy Wedbush
Start price
30.06.25
/
50%
€7.60
Target price
30.06.26
€15.36
Performance (%)
0.47%
Price
22:26
€7.64
Summary
This prediction is currently active. Since the start of the prediction for Biocryst Pharmaceuticals the price has only changed by 0.47%. This prediction currently runs until 30.06.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biocryst Pharmaceuticals | 0.47% |
iShares Core DAX® | 2.339% |
iShares Nasdaq 100 | 2.017% |
iShares Nikkei 225® | 4.496% |
iShares S&P 500 | 1.174% |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Wedbush from $16.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.80
25.02.25
25.02.25
€14.28
25.02.26
25.02.26
-2.13%
22:26
22:26